Skip to main content

Table 2 Distribution of anthropometric, smoking and disease status, specified by steatohepatitis, fatty liver and normal control groups

From: Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study

 

Steatohepatitis

N = 124

Fatty liver only

N = 124

Normal

N = 124

P value

n

(%)

n

(%)

n

(%)

 

Sex (women)

20

(5.4)

20

(5.4)

20

(5.4)

1.000

Smoking status (yes)

54

(14.5)

37

(10.0)

44

(11.8)

0.078

Hypertension (>=140/90 mmHg or medication)

45

(12.1)

32

(8.6)

22

(5.9)

0.004

Diabetes mellitus (fasting glucose> = 126

23

(6.2)

11

(3.0)

4

(1.1)

0.000

mg/dL or medication)

       

Obesity (BMI> = 27)

66

(17.7)

39

(10.5)

10

(2.7)

<.0001

High blood pressure (SBP> = 130 or

61

(16.4)

30

(8.1)

29

(7.8)

<.0001

DBP> = 85 mmHg)

       

Triglyceride ≧ 150 mg/dL

77

(20.7)

60

(16.1)

20

(5.4)

<.0001

HDL ≦ 40 (men) or 50 mg/dL (women)

46

(12.4)

33

(8.9)

22

(5.9)

0.003

Fasting glucose ≧ 110 (mg/dL)

40

(10.8)

20

(5.4)

7

(1.9)

<.0001

Metabolic syndrome (Yes)

59

(15.9)

17

(4.6)

6

(1.6)

<.0001